OXT and obesity due to melanocortin 4 receptor deficiency: Zhang, et al., showed that OXT and its analogs have multi-level effects in improving weight control, insulin sensitivity and insulin secretion, and bear potentials for being developed as therapeutic peptides for obesity and diabetes [164], not only in mice, but in humans as well.